$46.54
2.90% today
NYSE, Nov 26, 02:55 pm CET
ISIN
VGG111961055
Symbol
BHVN
Sector
Industry

Biohaven Pharmaceutical Holding Company Ltd. Target price 2024 - Analyst rating & recommendation

Biohaven Pharmaceutical Holding Company Ltd. Classifications & Recommendation:

Buy
100%

Biohaven Pharmaceutical Holding Company Ltd. Price Target

Target Price $64.74
Price $45.23
Potential
Number of Estimates 14
14 Analysts have issued a price target Biohaven Pharmaceutical Holding Company Ltd. 2025 . The average Biohaven Pharmaceutical Holding Company Ltd. target price is $64.74. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 15 Analysts recommend Biohaven Pharmaceutical Holding Company Ltd. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Biohaven Pharmaceutical Holding Company Ltd. stock has an average upside potential 2025 of . Most analysts recommend the Biohaven Pharmaceutical Holding Company Ltd. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -5.73 -8.80
31.46% 53.58%
P/E negative

15 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast for earnings per share. The average Biohaven Pharmaceutical Holding Company Ltd. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-8.80
Unlock
. This is
5.88% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-6.74 27.91%
Unlock
, the lowest is
$-9.76 4.39%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-5.73 31.46%
2024
$-8.80 53.58%
Unlock
2025
$-6.24 29.09%
Unlock
2026
$-5.39 13.62%
Unlock
2027
$-4.06 24.68%
Unlock
2028
$-1.47 63.79%
Unlock

P/E ratio

Current -4.84 8.28%
2024
-5.14 6.20%
Unlock
2025
-7.25 41.05%
Unlock
2026
-8.39 15.72%
Unlock
2027
-11.14 32.78%
Unlock
2028
-30.78 176.30%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today